GSK Future Growth

How is GSK forecast to perform in the next 1 to 3 years based on estimates from 21 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


2.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

LSE:GSK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202532,8766,4616,9308,82112
12/31/202430,7805,3116,5648,09320
12/31/202328,9234,8815,2357,19121
9/30/202238,4424,4567,4749,265N/A
6/30/202237,2404,5747,92710,506N/A
3/31/202236,1495,0827,43810,163N/A
12/31/202134,1144,3855,7937,952N/A
9/30/202126,3593,5676,0648,040N/A
6/30/202128,3783,9344,8716,339N/A
3/31/202130,1644,9837,0287,807N/A
12/31/202034,0995,7497,4578,441N/A
9/30/202034,2596,3716,8338,039N/A
6/30/202034,9986,6798,7519,693N/A
3/31/202035,1835,3806,6288,322N/A
12/31/201933,7544,6456,2618,020N/A
9/30/201933,0524,5616,8328,686N/A
6/30/201931,7594,4276,4888,248N/A
3/31/201931,2603,9046,7358,221N/A
12/31/201830,8213,6236,8818,421N/A
9/30/201830,2631,8625,5217,171N/A
6/30/201830,0141,6565,1406,991N/A
3/31/201830,0241,0354,5496,637N/A
12/31/201730,1861,5324,7646,918N/A
9/30/201730,1332,3354,7767,040N/A
6/30/201729,8321,9314,8656,910N/A
3/31/201729,0441,6765,2727,138N/A
12/31/201627,8899124,4286,497N/A
9/30/201626,5893013,2605,007N/A
6/30/201625,17431N/A3,721N/A
3/31/201624,530615N/A2,702N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: GSK's forecast earnings growth (2.5% per year) is above the savings rate (1%).

Earnings vs Market: GSK's earnings (2.5% per year) are forecast to grow slower than the UK market (10.2% per year).

High Growth Earnings: GSK's earnings are forecast to grow, but not significantly.

Revenue vs Market: GSK's revenue (4.2% per year) is forecast to grow slower than the UK market (4.2% per year).

High Growth Revenue: GSK's revenue (4.2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: GSK's Return on Equity is forecast to be high in 3 years time (31.6%)


Discover growth companies